Blueprint Genetics expands in North America by building a new CLIA/CAP NGS facility in Seattle
The need for more space and expansion of the North American team will support the strong growth in sample volumes, new customers and partnerships.
DelSiTech Ltd Receives Significant Funding for Developing Long-Acting Injectables for contraceptives and HIV antivirals development by the Bill & Melinda Gates Foundation
DelSiTech Ltd, a Finnish drug delivery and drug development company, today announced significant grant funding to support the development of long-acting controlled release formulations for family planning as well as for human immunodeficiency virus (HIV) antivirals, from the Bill & Melinda Gates Foundation.
Helsinki Biobank and Fimmic Introduce a Unique One Access Service for Biomedical Research
Tissue sample collections and digital services with deep learning -based image analysis solutions now available as a combined service
Helsinki Biobank and medical AI software company Fimmic announce a collaboration by presenting a unique one access service concept. The new service combines Helsinki Biobank´s large collection of pathology samples and world-class digital services with state-of-the art deep learning AI -based image analysis solutions from Fimmic.
- Life Science Mentors – Mentoring Service for Finnish Life Science Actors
- Faron Pharmaceuticals Admission to AIM and first day of dealings £10 million fundraise to progress Phase III clinical trial
- Faron Enters Agreement with Selexis SA to Progress Development of Novel Cancer Immunotherapy Clevegen
- Fimmic closes investment round to digitalize cancer diagnostics
- Faron Pharmaceuticals Oy Intention to Float on AIM
- Innomedica to open new office in Switzerland
- FIT Biotech’s Initial Public Offering Completed Successfully
- BioFinland prize to Biovian Oy
- Forendo Pharma announces the US licensing of fispemifene to Apricus Biosciences targeting urological conditions in men
- Oncos Therapeutics Demonstrates Systemic, Tumor-specific Immune Response by Local Administration of its Lead Product ONCOS-102
- Promising new treatment for life threatening acute respiratory distress syndrome (ARDS)
- A Special Year for the Biotech Sector
- KU Leuven and FIT Biotech enter into a worldwide license and collaboration agreement for the development of novel immunotherapeutics
- Neste Jacobs and Roal Sign a Contract to Expand Enzyme Production Plant
- BioFinland 2013 prize to Glykos Finland Ltd
- Culminatum Innovation and Diaceutics Collaborate to Provide Expert Training to Leading Finnish Researchers on Commercializing Biomarkers for Personalized Medicine
- Innomedica and CMC Biologics into strategic agreement for Japan market
- The Future Generation of Bioscientists - Lost or Found?
- Culminatum works to develop an attractive innovation environment for biotechnology in the BSR
- New Horizons For the Bioindustry
- Faron reports positive headline data from FPCLI001 clinical study with FP- 1201 in acute lung injuries
- An Insider’s View: Report on the Finnish Life Sciences Industry
- Faron and Maruishi Sign Traumakine-program License Agreement
- Rentschler to manufacture Faron product Traumakine®
- Change of management in Novamass Ltd
- Fulfilling the Promises
- Innomedica Expands in UK – Dr Jim Phillips Joins the Team
- Finland is a Forerunner in Biomass Refining
- Biobanks—Opportunities Becoming Reality
- The Perceived Value-added of Venture Capital Investors: Evidence from Finnish biotechnology industry
- Coaching small biotech companies into success: The value-adding function of VC
- Promoting innovation by tax incentives—A review of strategies and their importance to biotech growth
- European Biotech industry figures show signs of chronic under-funding
- ETLA 2004 Survey on the Finnish Biotechnology Industry--Background and Descriptive Statistics
- State of the Biotechnology Industry
- Intellectual Capital and Anticipated Future Sales in Small and Medium-sized Biotechnology Companies
- Ownership and Financial Structure of Biotechnology SMEs: Evidence from Finland
- Findings of the ETLA Survey on Finnish Biotechnology Firms